Before Invest
ELI LILLY & Co logo

ELI LILLY & Co

LLY
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Unlock 39 quarters
Period
Annual Quarterly
Order
RatiosJun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Mar 31, 2010Sep 30, 2009Jun 30, 2009
Gross Margin
85.78%
81.93%
82.91%
84.27%
82.53%
81.02%
80.80%
80.91%
80.42%
78.26%
76.63%
77.25%
Operating Margin
39.08%
45.03%
41.85%
44.14%
29.03%
13.34%
32.87%
28.62%
4.74%
25.57%
21.47%
24.15%
Pretax Margin
40.25%
44.70%
41.09%
43.56%
27.15%
13.89%
31.12%
28.92%
4.50%
25.13%
21.98%
22.55%
Effective Tax Rate
23.27%
16.43%
22.81%
16.47%
20.16%
38.91%
15.64%
11.56%
113.44%
15.59%
12.08%
7.27%
Net Margin
30.88%
37.36%
31.72%
36.38%
21.68%
8.48%
26.25%
25.58%
-0.60%
21.21%
19.32%
20.91%
Current Ratio
1.35x
1.50x
1.55x
1.28x
1.37x
1.27x
1.11x
1.35x
1.05x
1.13x
1.30x
1.13x
Debt to Equity
3.20x
2.74x
3.82x
4.50x
4.64x
4.28x
4.27x
3.96x
4.12x
3.92x
3.71x
3.67x
Net Debt to Equity
2.94x
2.57x
3.41x
4.32x
4.45x
4.04x
4.03x
3.77x
3.91x
3.67x
3.39x
3.41x
Asset Turnover
16.15%
16.98%
15.31%
15.42%
14.24%
15.13%
15.73%
13.71%
16.40%
15.16%
13.09%
14.63%
Return on Equity
20.94%
23.71%
23.41%
30.85%
17.41%
6.78%
21.76%
17.39%
-0.51%
15.81%
11.91%
14.28%
Return on Assets
4.99%
6.34%
4.86%
5.61%
3.09%
1.28%
4.13%
3.51%
-0.10%
3.22%
2.53%
3.06%